Study S001301

Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06980623
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 26000
Start: 2025-01-01
Primary completion: 2025-11-30
Lead sponsor: Brigham and Women's Hospital
Conditions: Type 2 Diabetes; Heart Failure
Interventions: DRUG:Tirzepatide; DRUG:Semaglutide
Results posted: FALSE

Registered primary outcomes

Hospitalization for heart failure and all-cause mortality [From treatment initiation to end of follow up, up to 48 months.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.